Cho, B. C. Et Al. 2024. Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC. NEW ENGLAND JOURNAL OF MEDICINE .

Cho, B. C., Lu, S., Felip, E., Spira, A. I., Girard, N., Lee, J., ... Lee, S.(2024). Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC. NEW ENGLAND JOURNAL OF MEDICINE .

Cho, Byoung Et Al. "Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC," NEW ENGLAND JOURNAL OF MEDICINE , 2024

Cho, Byoung C. Et Al. "Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC." NEW ENGLAND JOURNAL OF MEDICINE , 2024

Cho, B. C. Et Al. (2024) . "Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC." NEW ENGLAND JOURNAL OF MEDICINE .

@article{article, author={Byoung C. Cho Et Al. }, title={Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2024}